Key result
The L348P gain-of-function mutation in the M-domain of cardiac myosin-binding protein-C significantly increased its binding affinity for actin and enhanced force activation independent of calcium.
The tri-helix bundle of the cMyBP-C M-domain is crucial for regulating cardiac muscle contraction via actin binding, and its mutation can lead to functional changes associated with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
M-domain mutations may refine HCM variant classification; leaves open whether they alter clinical phenotypes or guide therapy.
The M-domain is the major regulatory subunit of cardiac myosin-binding protein-C (cMyBP-C) that modulates actin and myosin interactions to influence muscle contraction. However, the precise mechanism(s) and the specific residues involved in mediating the functional effects of the M-domain are not fully understood. Positively charged residues adjacent to phosphorylation sites in the M-domain are thought to be critical for effects of cMyBP-C on cross-bridge interactions by mediating electrostatic binding with myosin S2 and/or actin. However, recent structural studies revealed that highly conserved sequences downstream of the phosphorylation sites form a compact tri-helix bundle. Here we used site-directed mutagenesis to probe the functional significance of charged residues adjacent to the phosphorylation sites and conserved residues within the tri-helix bundle. Results confirm that charged residues adjacent to phosphorylation sites and residues within the tri-helix bundle are important for mediating effects of the M-domain on contraction. In addition, four missense variants within the tri-helix bundle that are associated with human hypertrophic cardiomyopathy caused either loss-of-function or gain-of-function effects on force. Importantly, the effects of the gain-of-function variant, L348P, increased the affinity of the M-domain for actin. Together, results demonstrate that functional effects of the M-domain are not due solely to interactions with charged residues near phosphorylatable serines and provide the first demonstration that the tri-helix bundle contributes to the functional effects of the M-domain, most likely by binding to actin. Background: Cardiac myosin-binding protein C (cMyBP-C) regulates heart muscle contraction by influencing actomyosin interactions. Results: Amino acids within the tri-helix bundle of the M-domain contribute to the functional effects of cMyBP-C. Conclusion: Amino acids outside of phosphorylation sites influence function of the M-domain. Significance: The tri-helix bundle is important to the regulatory role of cMyBP-C, likely through actin-binding interactions.
No takes yet. Share an insight, caveat, or question.
Bezold et al. (2013) studied Hypertrophic cardiomyopathy (context). L348P mutation in the M-domain of cMyBP-C vs. Wild-type C1C2 protein was evaluated on Actin binding affinity (Kd in μM) (p=<0.05). The L348P gain-of-function mutation in the M-domain of cardiac myosin-binding protein-C significantly increased its binding affinity for actin and enhanced force activation independent of calcium.
Synapse has enriched 10 related papers. Consider them for comparative context: